Data / Form D filings / TFF Pharmaceuticals, Inc.
TFF Pharmaceuticals, Inc.: Form D filings
TFF Pharmaceuticals, Inc., a pharmaceuticals company in Fort Worth, TX, filed 4 Form D notices with the SEC between 2018 and 2024. The latest, on April 2, 2024, reports an offering of $1.2 million with nothing sold yet to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1751 RIVER RUN, SUITE 400, Fort Worth, TX, 76107
- Phone
- (817) 438-6168
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1733413
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 2, 2024 | New notice | $1,180,000 | $0 | $1,180,000 | 2 | Mar 22, 2024 | sec.gov |
| Aug 19, 2020 | New notice | $25,913,560 | $25,913,560 | 23 | Aug 10, 2020 | sec.gov | |
| Jul 24, 2019 | New notice | $8,170,000 | $8,170,000 | 229 | May 16, 2019 | sec.gov | |
| Mar 27, 2018 | New notice | $14,155,000 | $14,155,000 | 224 | Mar 13, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| BRANDI S. ROBERTS | Director | |
| THOMAS S. KING | Director | |
| ROBERT S. MILLS, JR. | Director | |
| STEPHEN S. ROCAMBOLI | Director | |
| HARLAN S. WEISMAN | Executive Officer, Director | |
| ZAMANEH S. MIKHAK | Executive Officer | |
| KIRK S. COLEMAN | Executive Officer | |
| MICHAEL S. PATANE | Director | |
| CATHERINE S. LEE | Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
- InnovoTEX Inc. $749,951 · Aug 6, 2026
Every Form D from the week of Apr 1, 2024 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TFF Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.